REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
Covid-19

Sheba Teams with America’s NIH in Research Studies on COVID-19

Research Studies on covid-19
Israel has joined forces with the National Institutes of Health (NIH), the medical research agency of the US, in a joint research studies on covid-19 that aims to find treatments and the ultimate goal – a vaccine.

Sheba Medical Center and the NIH are collaborating to study the virological and immunological aspects of COVID-19. This partnership is significant for helping to accelerate research and a more comprehensive understanding of the novel coronavirus.

Clinical and scientific research studies on COVID-19 will be applied toward the development of effective treatments and vaccines against the virus. Sheba will provide blood samples, plasma, and virus samples from infected patients in Israel to the Vaccine Research Center of the NIH.

Additionally, the hospital is currently performing a series of clinical trials with various experimental treatments of its own and treatments from international pharmaceutical companies. Sheba will provide the NIH with relevant information amassed from these trials.

“This collaboration brings together the outstanding clinical acumen of Sheba Medical Center with our state-of-the-art approaches to the scientific investigation of human infectious disease,” said Dr. Daniel Douek, senior investigator at the Human Immunology Section in the NIH Vaccine Research Center. “I am certain that we will be able to contribute much to the resolution not only of this current pandemic but also of emerging infections in the future.”

Related

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More
Hemophilia research
News Sep 05.

New Sheba Study Indicates: Novel Treatment Sharply Reduces Bleed Rates Among Hemophilia Patients

Results indicate that a monthly treatment with Fitusiran significantly reduces bleed rates among both hemophilia A and B patients.
Read More